Proprietary AI analyst is now available

Green Cross Health Valuation Multiples

Discover revenue and EBITDA valuation multiples for Green Cross Health and similar public comparables like Profarma, Fangzhou, MARX Biotech, d1000 and more.

Green Cross Health Overview

About Green Cross Health

Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services and medical services. The majority of the revenue is generated from the Pharmacy services segment. Its pharmacy services segment includes operations like providing pharmacy services through consolidated stores, equity-accounted investments, and franchise stores. The medical service segment provides complete family healthcare services through general practitioners, accident, and medical centers.


Founded

1981

HQ

New Zealand

Employees

N/A

Sectors

Financials (FY)

Revenue: $307M
EBITDA: $33M

EV

$214M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Green Cross Health Financials

Green Cross Health reported last fiscal year revenue of $307M and EBITDA of $33M.

In the same fiscal year, Green Cross Health generated $175M in gross profit, $33M in EBITDA, and $12M in net income.

Revenue (LTM)


Green Cross Health P&L

In the most recent fiscal year, Green Cross Health reported revenue of $307M and EBITDA of $33M.

Green Cross Health is profitable as of last fiscal year, with gross margin of 57%, EBITDA margin of 11%, and net margin of 4%.

See analyst estimates for Green Cross Health
Last FY202320242025202620272028
Revenue$307M$283M$293M$304M
Gross Profit$175M$162M$168M$173M
Gross Margin57%57%57%57%
EBITDA$33M$26M$28M$32M
EBITDA Margin11%9%9%10%
EBIT Margin8%6%7%8%
Net Profit$12M$11M$8M$11M
Net Margin4%4%3%4%

Financial data powered by Morningstar, Inc.

Green Cross Health Stock Performance

Green Cross Health has current market cap of $159M, and enterprise value of $214M.

Market Cap Evolution


Green Cross Health's stock price is $1.11.

Green Cross Health share price increased by 23.2% in the last 30 days, and by 129.1% in the last year.

Green Cross Health has an EPS (earnings per share) of $0.08.

See more trading valuation data for Green Cross Health
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$214M$159M-1.0%23.2%55.9%129.1%$0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Green Cross Health Valuation Multiples

Green Cross Health trades at 0.7x EV/Revenue multiple, and 6.5x EV/EBITDA.

See NTM and 2027E valuation multiples for Green Cross Health

EV / Revenue (LTM)


Green Cross Health Financial Valuation Multiples

As of June 27, 2026, Green Cross Health has market cap of $159M and EV of $214M.

Green Cross Health has a P/E ratio of 13.8x.

Last FY202320242025202620272028
EV/Revenue0.7x0.8x0.7x0.7x
EV/EBITDA6.5x8.1x7.7x6.8x
EV/EBIT9.1x12.0x10.6x9.3x
EV/Gross Profit1.2x1.3x1.3x1.2x
P/E13.8x14.0x18.9x14.6x
EV/FCF8.4x9.7x8.5x8.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Green Cross Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Green Cross Health Margins & Growth Rates

In the most recent fiscal year, Green Cross Health reported gross margin of 57%, EBITDA margin of 11%, and net margin of 4%.

See estimated margins and future growth rates for Green Cross Health

Green Cross Health Margins

Last FY202420252026202720282029
Gross Margin57%57%57%57%
EBITDA Margin11%9%10%11%
EBIT Margin8%7%8%8%
Net Margin4%3%4%4%
FCF Margin8%9%8%8%

Green Cross Health Growth Rates

23/2424/2525/2626/2727/2828/29
Revenue Growth4%4%1%
Gross Profit Growth4%3%1%
EBITDA Growth5%14%3%
EBIT Growth13%14%3%
Net Profit Growth(26%)29%6%
FCF Growth15%2%(1%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Green Cross Health Operational KPIs

Green Cross Health's Rule of 40 is 12% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Green Cross Health's Rule of X is 13% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Green Cross Health
Last FY202320242025202620272028
Rule of 4012%---
Bessemer Rule of X13%---
G&A Expenses to Revenue37%37%37%37%
Opex to Revenue49%51%51%49%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Green Cross Health Competitors

Green Cross Health competitors include Profarma, Fangzhou, MARX Biotech, d1000, Talea Group, BlueMTec, PetMeds, SC Ropharma, Dimed SA and JZJ Chain Drugstore.

Most Green Cross Health public comparables operate across Pharmacies.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Profarma0.2x-4.0x-
Fangzhou0.2x0.1x16.3x12.0x
MARX Biotech4.9x-34.5x-
d10000.3x-4.1x-
Talea Group0.6x-24.4x-
BlueMTec0.5x-71.3x-
PetMeds0.1x0.1x(0.8x)(0.5x)
SC Ropharma0.2x-4.4x-

This data is available for Pro users. Sign up to see all Green Cross Health competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Green Cross Health

When was Green Cross Health founded?Green Cross Health was founded in 1981.
Where is Green Cross Health headquartered?Green Cross Health is headquartered in New Zealand.
Is Green Cross Health publicly listed?Yes, Green Cross Health is a public company listed on New Zealand Exchange.
What is the stock symbol of Green Cross Health?Green Cross Health trades under GXH ticker.
When did Green Cross Health go public?Green Cross Health went public in 2000.
Who are competitors of Green Cross Health?Green Cross Health main competitors include Profarma, Fangzhou, MARX Biotech, d1000, Talea Group, BlueMTec, PetMeds, SC Ropharma, Dimed SA, JZJ Chain Drugstore.
What is the current market cap of Green Cross Health?Green Cross Health's current market cap is $159M.
What is the current revenue of Green Cross Health?Green Cross Health's last fiscal year revenue is $307M.
What is the current EV/Revenue multiple of Green Cross Health?Current revenue multiple of Green Cross Health is 0.7x.
Is Green Cross Health profitable?No, Green Cross Health is not profitable.
How many companies Green Cross Health has acquired to date?Green Cross Health hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Green Cross Health has invested to date?Green Cross Health hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Green Cross Health

Lists including Green Cross Health

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial